chrisvoncsefalvay/vaers-outcomes huggingface dataset:
that year I got about six flus different ones; Initial information received on 20-Feb-2022 regarding an unsolicited valid non-serious case received from a consumer via social media.  This case involves an unknown age and unknown gender patient who experienced that year i got about six flus different ones while receiving vaccine influenza vaccine.   The patient's past medical history, medical treatment(s), vaccination(s), concomitant medications, and family history were not provided.    On an unknown date, the patient received one dosage of suspect influenza vaccine produced by unknown manufacturer (formulation,strength, dose, route, batch number and expiry date) in unknown administered site for prophylactic vaccination. Information on batch number is requested.   On an unknown date the patient developed "that year i got about six flus different ones" (influenza) (unknown latency) following the administration of influenza vaccine.  Action taken:not applicable.  It was not reported if the patient received a corrective treatment for the event (that year I got about six flus different ones).  At time of reporting, the outcome was Unknown for the event that year i got about six flus different ones.
Patient was  given  second dose of Moderna vaccine at  a 21 day interval not 28
Warm touch at the injection site; rump at injection site; Red rump at the injection site; Swollen rump at site of injection; This spontaneous case was reported by a health care professional and describes the occurrence of INJECTION SITE WARMTH (Warm touch at the injection site), INJECTION SITE MASS (rump at injection site), INJECTION SITE ERYTHEMA (Red rump at the injection site) and INJECTION SITE SWELLING (Swollen rump at site of injection) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20-2A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jan-2021, the patient experienced INJECTION SITE WARMTH (Warm touch at the injection site), INJECTION SITE MASS (rump at injection site), INJECTION SITE ERYTHEMA (Red rump at the injection site) and INJECTION SITE SWELLING (Swollen rump at site of injection). At the time of the report, INJECTION SITE WARMTH (Warm touch at the injection site), INJECTION SITE MASS (rump at injection site), INJECTION SITE ERYTHEMA (Red rump at the injection site) and INJECTION SITE SWELLING (Swollen rump at site of injection) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. The patient was treated with Benadryl and applied Hydrocortisone.
60 y/o female, with past medical history HTN, anxiety, high cholesterol, and artery stenosis seen today for report of feeling lightheaded, hot flashes, tremors and the feeling of something cold running through her legs going to her stomach about 5 minutes post vaccination. Patient also reports that she took her medications this morning. (amlodipine 5 mg, HCTZ 12.5 mg, Atorvastatin 40 mg, metoprolol ER 100 mg, and escitalopram 10 mg. Patient states that this is her second dose in the series. NP and Paramedics at patient side. Patient is hypertensive despite taking all blood pressure medications. B/P 184/88, HR 78, 99% RA, 19 Resp, bs 108). Bottle of water provided to patient and her legs were elevated on a chair. Repeat BP obtained.  Patient BP decreased to 187/82. Patient blood pressure is still elevating 152/76 and still complains of coldness feeling that moves to her abdomen. Patient advise to go the hospital.  Patient and her husband agree to go the hospital. Patient transferred to the hospital accompanied by her husband.
Paralysis on left side of her body (patient reports that she could not move the left side of her body -arms and legs). Patient noticed in the morning upon waking up two days after her vaccination. As a result, she fell and broke her right foot.
I got the first shot, and the area of the shot was a little red but after a week the whole upper part of my arm was swollen. It was itchy feverish and swollen and the redness spread down to my elbow.  The doctor gave me antibiotics and a Benadryl cream. My arm was still swollen even after the whole dose of antibiotics. I got the second dose in the other arm, the rash came up a little sooner but I was ready, and I used the Benadryl right away and it went down.
Systemic: Flushed / Sweating-Medium, Systemic: Hyperventilation-Medium, Systemic: Nausea-Mild, Additional Details: pt unable to tell if vaccine reaction or anxiety attack
Death - Symptom onset date 04/24/21 to include chills, loss of taste/smell, headache, fatigue, cough, SOB, nausea, vomiting and diarrhea.
A report has been received from a health professional concerning a 28 year old, female patient. The patient's medical history and concomitant medications were not reported. On an unknown date, the nurse administered FLUMIST to a patient and an employee in training, had a bit of FLUMIST squirted into her eye. A week later, the employee said there were no late occurring events. The outcome of the event of FLUMIST inadvertently sprayed into eye was unknown. The report was considered to be non-serious by reporter. Corrected report 30-Oct-2012: reporter health care professional changed to administered by, event coding changed from wrong technique in drug usage to accidental exposure, case category changed from B to C-Kur. Corrected report 06-Dec-2012: The coding of FLUMIST inadvertently sprayed into eye was changed from accidental exposure while administering drug to drug administration error and case category changed from C-Kur to B. The case has been updated with full date due to term additions for FLUMIST / Q/Laiv.
Left thigh erythema and induration around vaccination site. Reaction probable cause from VARIVAX.
pt recvd vax 25AUG92; around 7PM fussy & t103 about 8-830PM started jerking (head, arms & legs); moved eyes from side to side saying yes; mom feels had visual problems; became limp; these sx lasted around 45 mins a/10PM, temp down gave APAP
Pain in left shoulder and arm radiating to fingers.  Deceased range of motion; received cortisone shot and physical therapy to improve symptoms.  Injection given near top of left shoulder.  Pain continues.
20-25 minutes of unconsolable crying, uncontrolled crying, swelling, and slight redness.
Case number PHEH2013US021151 is an initial spontaneous report from the consumer (patient's friend) received on 08 Oct 2013. This report refers to a male patient. The patient's medical history and concomitant medications were not reported. The patient was vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) on 07 Oct 2013. On the same date, while returning from the clinic the patient suddenly passed out while driving. It was reported that he went off the road and his car flipped over. The patient had bumps and bruises, but he was fine and refused to visit the emergency room. The outcome of the events was reported as recovered. The events were reported as serious by the reporter. The causality of the events was not reported.
66-year-old female with a history of COPD, diabetes, hyperlipidemia, hypertension, and noncompliant with her home oxygen.  She is supposed to wear 2 L all the time however she gave her oxygen to a friend because "he needed it more than her.  She states over the last 3 days she has been in bed because she is too short of breath to move around.  She feels good as long as she is sitting still.  She has had some nasal congestion over the last couple of weeks.  She has an occasional cough which she states has had for some time.  She is a former smoker.  Patient denies pain.  No fever or chills.  She does have decreased appetite. Associated Symptoms: cough, orthopnea, shortness of breath, URI symptoms, wheezing
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 39-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 20Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 38 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: COVID 19 Treatment. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course- Known allergies: No. COVID 19 Treatment included anti-viral Paxlovid started from 24Jul2022.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Patient recieved four vaccines on June 16th, 2022.  The MMRII Vaccine which is to be administered under the skin, was instead injected into the patient's deltoid muscle.  Patient did not immediately complain of discomfort, and when contacted to return for proper administration, stated that she would return in 28 days.
Muscles in neck close to jaw tight after event.; Chewing makes jaw lock.; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 18Apr2021 at 13:30 (at the age of 41-year-old) as a single dose for COVID-19 immunisation. Medical history included pre-diabetic, allergy, seasonal allergy, and cramps. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included diphenhydramine, paracetamol, phenylpropanolamine hydrochloride (BENADRYL) for allergy and ibuprofen sodium (IBUPROFEN) for cramps. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 28Mar2021 at 14:45 (at the age of 41-year-old) as a single dose for COVID-19 immunisation. On 20Apr2021 at 06:00 the patient had mouth locked up and could not move jaw for a minute or so. Chewing made jaw lock. The patient could only chew in tiny bites. It started 2nd day after shot and muscles in jaw tight. Muscles in neck close to jaw tight after event. Symptom did not seem to be improving. No therapeutic measures were taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events muscle tightness and lock jaw were not recovered at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever) and CHILLS (chills) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048B21A) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis.    On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-May-2021, the patient experienced PYREXIA (fever) and CHILLS (chills). On 10-May-2021, PYREXIA (fever) and CHILLS (chills) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.
stabbing pain; Fever; Chills; Headache; muscle aches , back in knots; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of PAIN (stabbing pain), PYREXIA (Fever), CHILLS (Chills), HEADACHE (Headache) and MYALGIA (muscle aches , back in knots) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History was provided by the reporter.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 05-Feb-2021, the patient experienced PAIN (stabbing pain), PYREXIA (Fever), CHILLS (Chills), HEADACHE (Headache) and MYALGIA (muscle aches , back in knots).   At the time of the report, PAIN (stabbing pain), PYREXIA (Fever), CHILLS (Chills), HEADACHE (Headache) and MYALGIA (muscle aches , back in knots) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Severe chills at 11:30 pm night of vaccine.  Lasted 1  1/2 hours.  Woke up next day with mild fever and slight headache. Both went away shortly thereafter. Felt lethargic all day, little appetite.  Felt 100% better next day.
Within 15 minutes complained of numbness entire length of arm. Within 30 minutes, hot and flushed, SOB upon lying down, started to vomit twice. Within 2 hrs, diarrhea onset lasting 48 hours. Taken home. Vomited 3 times. Unable to function. At 40 hrs from onset had severe headache lasting 8 hours.
left arm where she received the shot hurts so much that she cannot lift it; headache; fever; nausea; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (left arm where she received the shot hurts so much that she cannot lift it), HEADACHE (headache), PYREXIA (fever) and NAUSEA (nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in December 2020 and Headache (very bad headache from the COVID).    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced PAIN IN EXTREMITY (left arm where she received the shot hurts so much that she cannot lift it), HEADACHE (headache), PYREXIA (fever) and NAUSEA (nausea). At the time of the report, PAIN IN EXTREMITY (left arm where she received the shot hurts so much that she cannot lift it), HEADACHE (headache), PYREXIA (fever) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided. Patient stated that she wanted to know whether she can take Tylenol for the fever and pain.
Weeks after the shot: pain in joints, hands at first, wrists, then progressively much worse all over the body. In a period of 8 months full health turned into INABILITY TO WALK, saw a Doctor that diagnosed severe rheumatoid arthritis. RA doesn't begin at mid 60s, its definitely resulted from the H1N1 flu shot.
Redness around arm below injection site; prescribed Keflex 500mg per mouth ever 6 hours for 7 days.
Lower Back and neck stiffness; unable to bend over or turn neck as I normally would; I have tried to take over the counter medicine (Tylenol/ibuprofen) and also have tried to get adjusted by Chiropractor. Nothing helps. In the morning my lower back is so stiff it is hard to even get out of bed.
This spontaneous report was received from a pharmacist refers to a 67 year old female non-pregnant patient with hypercholesterolemia and thyroid (unspecified disorder). On 15-OCT-2014, the patient was vaccinated with PNEUMOVAX23, 25/0.5 Y, injection (lot # K010522; Exp. Date: 25-FEB-2016) in the arm as routine administration (dose, route, and dose number not provided). Concomitant therapies included CRESTOR, levothyroxine sodium (manufacturer unknown) and PREMARIN.  On 15-OCT-2014, the patient experienced red, swelling and painful rash at and around the injection site after received with PNEUMOVAX23. Patient experienced bulbous swelling and nodule type thing that was a big hard lump described as the size of a tennis ball or racquetball at the injection site and going up to the shoulder. No treatment was given for the event. Labs diagnostics studies were not performed. The patient sought medical attention.  At the time of the report, the outcome of the events was unknown. The casual relationship between PNEUMOVAX23 and the events was unknown. Additional information has been requested.
I woke up the next day after the vaccines with all-over muscle soreness at a mild level. I felt tired and run down at a mild to medium level. I had a low-grade headache. I took 500mg of Tylenol. I believe this is from the shingles vaccine as I get the flu vaccine every year with no problem.
Weakness in his legs; went up falling and breaking his hip; went up falling and breaking his hip; fell ill as he had fever close to 102.8 fever; This is a spontaneous report from a contactable consumer (reporting for father). A 75-year-old male patient received the 2nd dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration administered on arm on 08Apr2021 (Batch/Lot Number: EW0151) as SINGLE DOSE for COVID-19 immunization.  Medical history included hypertension, diabetes mellitus and leg bypass surgery. The patient took many medications (unspecified). The patient received the first dose of PFIZER-BIONTECH COVID-19 VACCINE on unknown date ( Batch/Lot Number not provided) as COVID-19 immunization. The reporter just recently found out that the patient got the 2nd dose of vaccine on 08Apr2021. On unspecified date, he fell ill as he had fever close to 102.8 fever. The patient also has weakness in his legs and he went up falling and breaking his hip/ fractured his hip.  The patient was admitted on the hospital on that same unspecified day and was being treated for his hip which require the partial hip replacement surgery. Outcome of the events were unknown.  No follow-up attempts are needed. No further information is expected.
Pt reports vaginal bleeding starting the day after first covid vaccination. Unknown which vaccine was given Last period a week before vaccination day
Weakness; micro and lipochrome  values that usually are around 1 increased to 3 and 2 respectively; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Weakness) and PIGMENTATION DISORDER (micro and lipochrome  values that usually are around 1 increased to 3 and 2 respectively) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046B21A and 047A21A) for COVID-19 vaccination.     Concurrent medical conditions included Thalassemia minor. Concomitant products included LOSARTAN for Hypertension, ATENOLOL for an unknown indication.   On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ASTHENIA (Weakness) and PIGMENTATION DISORDER (micro and lipochrome  values that usually are around 1 increased to 3 and 2 respectively). At the time of the report, ASTHENIA (Weakness) and PIGMENTATION DISORDER (micro and lipochrome  values that usually are around 1 increased to 3 and 2 respectively) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment medications were reported. Lab data- blood work was performed. Micro and lipochrome values were increased to 3 and 2 respectively   This case was linked to MOD-2021-347566 (Patient Link).
This case was reported by a consumer via call center representative and described the occurrence of shoulder discomfort in a 63-year-old male patient who received SHINGRIX for prophylaxis. On 31st August 2018, the patient received the 1st dose of SHINGRIX. In September 2018, less than a month after receiving SHINGRIX, the patient experienced shoulder discomfort, back pain, shoulder pain, head pressure, headache, sinusitis, increased blood pressure, unwell, bone pain and ill-defined disorder. On an unknown date, the outcome of the shoulder discomfort, back pain, shoulder pain, head pressure, headache, sinusitis, increased blood pressure, unwell, bone pain and ill-defined disorder were recovered/resolved. It was unknown if the reporter considered the shoulder discomfort, back pain, shoulder pain, head pressure, headache, sinusitis, increased blood pressure, unwell, bone pain and ill-defined disorder to be related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX in the left arm. The patient reported that he had a reaction and he was not well. The patient experienced discomfort from his left shoulder which moved to his right shoulder and then on to his collarbone. The patient also had back pain and medical issues that lasted for several weeks and months. The patient reported pain in his back and shoulder and he had head pressure with headaches and sinus issues. The patient also experienced elevated blood pressure and he saw a cardiologist and neurologist and they found nothing. These symptoms all started during September and into October and they had all fully resolved at the time of reporting. The reporter gave consent to follow up.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On an unknown date, the patient was vaccinated with a dose of improperly stored VARIVAX, for prophylaxis (dose, route of administration, lot number and expiration date were not reported); which was reconstituted with sterile diluent (MRK INJ) (dose, route of administration, lot number and expiration date were not reported). The administered dose of the vaccine experienced a temperature excursion of 15 to 46 degrees Fahrenheit for 1 hour and 20 minutes. There was no previous temperature excursion. It was called because of a data logger. There was not adverse effect reported. No product quality complaint was involved.
approx 1 1/2hr p/vax exp inconsolable crying & irritability;the irritability lasted for 1-2hr;
Red, itchy, swollen rash on the injection arm. Not exactly surrounding the injection site, below it. Rash is circular and 3-4 inches in diameter. Rash started 7 days after the injection. Rash is warm to the touch
12AUG91 t104, allergic event 1 hr post immun had nausea & difficult breathing & screaming >3hrs episode;
Stomach upset started on 11-30-2021 off and on. Then was better on Friday/Saturday/Sunday. Returned on Monday.  Then intermittent but says pain is a 10 sometimes. Monday diarrhea twice. Tuesday diarrhea 7 times. Wednesday diarrhea 2 times.  Thursday diarrhea is continuing despite BRAT diet being used this week.
Pharmacy administered the incorrect dose (and later stated that they've done this for every administration of the bivalent Moderna dose)
Pt was mistakenly given 1.5 mL of typhoid VICPs and anthrax vaccines, instead of 0.5 mL.